摘要
Gamma delta(γδ) T细胞表达Vγ9Vδ2 T细胞受体,占外周血T淋巴细胞的2%~5%左右,主要分布于黏膜相关淋巴组织,是T细胞的亚群之一。其免疫作用介于固有免疫和适应性免疫之间,为主要组织相容性复合体( MHC)非限制性细胞,具有一定的非特异性杀伤肿瘤细胞的作用,并且具有广泛的抗瘤谱。许多研究证实γδ T细胞参与了机体免疫防御系统的第一道防线,未来以γδ T细胞为基础的细胞免疫疗法,将会成为肿瘤免疫治疗的新战略。本文将对γδ T细胞的抗肿瘤作用机制及其临床应用作一综述。
Gamma delta(γδ) T cells are minor subset of T lymphocytes( 2%-5% of peripheral blood T lymphocytes) that ex-press Vγ9Vδ2 T cell receptors, mainly distributed in the mucosa-associated lymphoid tissue, are non-restricted cells of major histocom-patibility complex( MHC) , can kill various tumor cells. Many data demonstrate thatγδT cells are involved in the first line of immune defense system. In the future, adoptive γδ T cells-based cell immunotherapy will become a new strategy for cancer immunotherapy. In this review, we provide an overview of its anti-tumor mechanism and clinical application.
出处
《临床肿瘤学杂志》
CAS
2014年第4期375-378,共4页
Chinese Clinical Oncology
关键词
γδ
T细胞
免疫治疗
肿瘤
Gamma delta T cells
Immunotherapy
Tumor